MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
BCLI
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Brainstorm Cell Therapeutics (BCLI) Ownership - Who owns Brainstorm Cell Therapeutics?

Brainstorm Cell Therapeutics Inc is a biotechnology company committed to the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis, progressive multiple sclerosis, Alzheimer's disease, and other neurodegenerative diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Computer Peripherals
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.61M
P/E Ratio
N/A
Total Cash
5K
Projected Growth
N/A
Total Debt
427K
Revenue
N/A
Risk (Beta)
1.95
Dividend Yield
N/A
Total Cash/Share
0.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for BCLI
A.I. Advisor
published General Information

General Information

a biotechnology company, which develops innovative adult stem cell therapeutic products

Industry Biotechnology

Profile
Details
Industry
Computer Peripherals
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A